Literature DB >> 16195169

Schnitzler's syndrome treated successfully with intravenous pulse cyclophosphamide.

D Peterlana1, A Puccetti, E Tinazzi, S Simeoni, C Lunardi.   

Abstract

Schnitzler's syndrome is a rare clinical condition characterized by chronic urticaria, intermittent fever, bone pain, arthralgia or arthritis, and monoclonal immunoglobulin M (IgM) gammopathy. Here we describe the case of a 48-year-old Italian female with a long history of arthralgia, leucocytosis, spiking fever, and chronic urticaria with severe pruritus. The IgM-kappa monoclonal component in the serum and bone densification on conventional X-ray with hyperfixation on bone technetium scanning at the distal part of the femurs and at the proximal part of the tibias were detected 4 years after the onset of the symptoms. After many ineffective treatments, the use of pulse cyclophosphamide (CPX) resulted in complete remission of the disease that is still lasting after a 2-year follow-up.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16195169     DOI: 10.1080/03009740510017733

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  3 in total

1.  Immunoglobulins during different treatment regimes in Schnitzler's syndrome.

Authors:  Rene Thonhofer
Journal:  Rheumatol Int       Date:  2010-12-02       Impact factor: 2.631

Review 2.  Schnitzler's syndrome: lessons from 281 cases.

Authors:  Heleen D de Koning
Journal:  Clin Transl Allergy       Date:  2014-12-05       Impact factor: 5.871

3.  Schnitzler's syndrome: a case report.

Authors:  Gabriel Tinoco; Rehan Kanji; Deepthi Moola
Journal:  Case Rep Med       Date:  2013-06-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.